Erratum: Improved cutaneous healing in diabetic mice exposed to healthy peripheral circulation (Journal of Investigative Dermatology (2009) DOI: 10.1038/jid.2009.60);Improved cutaneous healing in diabetic mice exposed to healthy peripheral circulation

Journal of Investigative Dermatology

Volumn 129, Issue 9, 2009, Pages 2265-2274

  Pietramaggiori, Giorgio ^a,b,c   Scherer, Sandra S ^a,b   Alperovich, Michael ^a,b   Chen, Bin ^b   Orgill, Dennis P ^b   Wagers, Amy J ^a,d  

^a Harvard University   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HUMORAL ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHIMERA; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; HISTOLOGY; LEUKOCYTE; MORPHOLOGY; MOUSE; NONHUMAN; PARABIOSIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SKIN INJURY; TISSUE REGENERATION; WILD TYPE; WOUND HEALING;

EID: 70349742558     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.136     Document Type: Erratum

References (37)

1. Amano H, Yamamoto H, Senba M, Oishi K, Suzuki S, Fukushima K et al. (2000) Impairment of endotoxin-induced macrophage inflammatory protein 2 gene expression in alveolar macrophages in streptozotocin-induced diabetes in mice. Infect Immun 68:2925-2929
2. Angelini F, Del Duca E, Piccinini S, Pacciani V, Rossi P, Manca Bitti ML (2005) Altered phenotype and function of dendritic cells in children with type 1 diabetes. Clin Exp Immunol 142:341-346
3. Ashcroft GS, Horan MA, Ferguson MW (1995) The effects of ageing on cutaneous wound healing in mammals. J Anat 187(Part 1):1-26
4. Awad O, Jiao C, Ma N, Dunnwald M, Schatteman GC (2005) Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Stem Cells 23:575-583
5. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C et al. (2007) Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317:807-810
6. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Med 10:858-864
7. Chan RK, Liu PH, Pietramaggiori G, Ibrahim SI, Hechtman HB, Orgill DP (2006) Effect of recombinant platelet-derived growth factor (Regranex) on wound closure in genetically diabetic mice. J Burn Care Res 27:202-205
8. Coleman DL (1982) Diabetes-obesity syndromes in mice. Diabetes 31:1-6
9. Coleman DL, Hummel KP (1969) Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 217:1298-1304
10. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433:760-764
11. Facchiano F, Lentini A, Fogliano V, Mancarella S, Rossi C, Facchiano A et al. (2002) Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo. Am J Pathol 161:531-541
12. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366:1736-1743
13. Fruhbeck G, Gomez-Ambrosi J (2001) Rationale for the existence of additional adipostatic hormones. FASEB J 15:1996-2006
14. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N et al. (2004) Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164:1935-1947
15. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG et al. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 117:1249-1259
16. Goldblum OM, Alvarez OM, Mertz PM, Eaglstein WH (1983) Dimethyl sulfoxide (DMSO) does not affect epidermal wound healing. Proc Soc Exp Biol Med 172:301-307
17. Jacobi J, Jang JJ, Sundram U, Dayoub H, Fajardo LF, Cooke JP (2002) Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 161:97-104
18. Lagasse E, Weissman IL (1996) Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods 197:139-150
19. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC (2003) Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162:303-312
20. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC et al. (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195-199
21. Michaels Jt, Dobryansky M, Galiano RD, Bhatt KA, Ashinoff R, Ceradini DJ et al. (2005) Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor administration. Wound Repair Regen 13:506-512
22. Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S (2005) Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 304:81-90
23. Pietramaggiori G, Kaipainen A, Czeczuga JM, Wagner CT, Orgill DP (2006) Freeze-dried platelet-rich plasma shows beneficial healing properties in chronic wounds. Wound Repair Regen 14:573-580
24. Pietramaggiori G, Kaipainen A, Ho D, Orser C, Pebley W, Rudolph A et al. (2007) Trehalose lyophilized platelets for wound healing. Wound Repair Regen 15:213-220
25. Pietramaggiori G, Scherer SS, Mathews JC, Alperovich M, Yang HJ, Neuwalder J et al. (2008) Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen 16:218-225
26. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE et al. (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22:382-387
27. Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ et al. (2005) Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 102:9194-9199
28. Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K et al. (2006) Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes 55:2245-2255
29. Steed DL (2006) Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 117:143S-9S; discussion S150-1
30. Sullivan SR, Underwood RA, Gibran NS, Sigle RO, Usui ML, Carter WG et al. (2004) Validation of a model for the study of multiple wounds in the diabetic mouse (db/db). Plast Reconstr Surg 113:953-960
31. Terashi H, Izumi K, Deveci M, Rhodes LM, Marcelo CL (2005) High glucose inhibits human epidermal keratinocyte proliferation for cellular studies on diabetes mellitus. Int Wound J 2:298-304
32. Waldorf AR, Levitz SM, Diamond RD (1984a) In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 150:752-760
33. Waldorf AR, Ruderman N, Diamond RD (1984b) Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 74:150-160
34. Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J, Frank S (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 115:245-253
35. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL (2001) Physiological migration of hematopoietic stem and progenitor cells. Science 294:1933-1936
36. www.idf.org/home/index.cfm. Complications of Diabetes in the United States
37. Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K et al. (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 139:57-64